
Europe’s Drug Supply Is Shifting Back Home: Is Germany Ready?
The article examines Europe’s medicine supply challenges and Germany’s role in strengthening pharmaceutical manufacturing. It covers EU policy changes, Germany’s industrial strengths and investment barriers, dependence on overseas API suppliers, and the importance of reliable production capacity. It also explores how manufacturers can reduce shortages by improving existing facilities, managing supplier risks and removing production bottlenecks.














































